Zacks Company Profile for Sensus Healthcare, Inc. (SRTS : NSDQ) |
|
|
|
Company Description |
Sensus Healthcare, Inc. is a medical device company It specializes in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The company's portfolio of treatment devices consists of the SRT-100(TM) and SRT-100 Vision(TM). Sensus Healthcare, Inc. is headquartered in Boca Raton, Florida.
Number of Employees: 54 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $4.74 |
Daily Weekly Monthly
 |
20 Day Moving Average: 55,856 shares |
Shares Outstanding: 16.44 (millions) |
Market Capitalization: $77.95 (millions) |
Beta: 1.29 |
52 Week High: $9.33 |
52 Week Low: $4.01 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
0.42% |
-3.93% |
12 Week |
5.80% |
-13.68% |
Year To Date |
-31.50% |
-35.07% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Joseph Sardano - Chief Executive Officer and Chairman
Javier Rampolla - Chief Financial Officer
Megan Cornish - Director
William H. McCall - Director
Anthony B. Petrelli - Director
|
|
Peer Information
Sensus Healthcare, Inc. (ABMD)
Sensus Healthcare, Inc. (DMDS)
Sensus Healthcare, Inc. (CPWY.)
Sensus Healthcare, Inc. (EQUR)
Sensus Healthcare, Inc. (ECIA)
Sensus Healthcare, Inc. (FMS)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 81728J109
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/14/25
|
|
Share - Related Items
Shares Outstanding: 16.44
Most Recent Split Date: (:1)
Beta: 1.29
Market Capitalization: $77.95 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $0.01 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $0.11 |
Payout Ratio: 0.00 |
Number of Estimates in the Fiscal Year Consensus: 2.00 |
Change In Payout Ratio: 0.00 |
Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/14/25 |
|
|
|
|